AJU Pharm
Privately held: no public share price · South Korea
Assets
(2 total)
2Total Assets
0Approved
2Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Dapagliflozin/linagliptin (Dapalina)No recent activity | Phase 3 | SGLT2;DPP-4Small molecule | Type 2 Diabetes |
| Phase 3 | Angiotensin II receptor / Calcium channel / Thiazide-like diureticSmall molecule | Hypertension |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.